Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Indiana for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Indiana only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Indiana (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Howard Lazarus (NPI 1063411635)

Field	Value
Entity Type	Individual
Organization	Howard Lazarus
Address	519 State St
City	New Albany
State	IN
ZIP	47150
Taxonomy	Retina Specialist (Ophthalmology) Physician
NPI Enumerated	July 18, 2005

Payer Source	Total Paid
Medicare	$1.9M
Medicaid	$0

Key Findings

This provider’s revenue is effectively single‑payer: Total Medicare revenue is $1.9M and there is no Medicaid billing on file, so Medicare dominates the payer mix and any revenue or utilization shifts in Medicare will proportionally impact the practice. The absence of Medicaid activity suggests limited exposure to state managed‑care flows and that payer negotiations or network coverage strategies should be evaluated in the context of Medicare only.

Revenue concentration is high and driven by a very small set of biological injection codes: the precomputed top‑3 Medicare codes (J0178, J2777, J3490) account for 78.8% of total Medicare revenue. In raw values those top codes are J0178 = $1M (54.2%), J2777 = $348K (18.2%), and J3490 = $123.1K (6.4%), indicating the practice’s income is heavily dependent on intravitreal drug administration and unclassified drug charges.

The code mix and descriptions indicate a retina‑focused, injection‑driven practice model: J0178 (aflibercept) and J2777 (faricimab) are high‑revenue intravitreal biologic injections, supported by additional retinal therapies such as J2781 (pegcetacoplan) and J7312 (dexamethasone implant). Procedural and imaging codes (67028, 67036, 67041, 92134, 92250) appear but represent much smaller shares of revenue, consistent with a clinic that primarily delivers frequent outpatient injections supplemented by diagnostic imaging and occasional surgery.

Competitive standing on the principal drug codes is modest rather than dominant nationally: J0178 ranks #820 of 3204 providers (74th percentile) and is described as "typical, unremarkable volume," while J2777 ranks #882 of 2039 (57th percentile, typical) and J3490 ranks #1221 of 2838 (57th percentile, typical). These ranks indicate the provider participates at or above median national activity for these drugs but is not a top national high‑volume outlier.

There is a pronounced statistical outlier in office E/M volume: 99213 produced 1.3K claims and $71.6K (3.7% of Medicare revenue) and is labeled an "extreme outlier, far above typical national volume" (rank #3583 of 457151, 99th percentile). This suggests very high clinic throughput for established‑patient visits, likely reflecting frequent follow‑up visits tied to injection protocols and ongoing disease management.

Diagnostic imaging intensity is notable: 92134 shows 1.3K claims and $34.4K (1.8% of Medicare revenue) and ranks #1777 of 26868 providers (93th percentile) while being characterized as "typical, unremarkable volume." The combination of high OCT claim counts with heavy injection coding supports a workflow centered on repeated imaging to guide intravitreal therapy decisions.

Although surgical codes are present, they are a minor revenue component: entries such as 67028 (1K claims, $87.5K, 4.6% of revenue) and 67036 (25 claims, $15.9K, 0.8% of revenue) appear at mid to low national ranks and together represent a small fraction of total Medicare revenue compared with injections. This pattern reinforces the view of a clinic focused on ambulatory injection services with episodic surgical interventions rather than a surgery‑centric practice.

The provider’s NPI tenure is long: enumerated 2005‑07‑18 (~21 years ago), indicating an established presence in the market. Combined with the concentrated drug revenue base (top‑3 = 78.8% of Medicare revenue) and no Medicaid activity, analysts should treat this as a long‑standing, Medicare‑dependent retina practice with operational sensitivity to Medicare drug reimbursement and injection utilization trends.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

19 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	1,500	$690	$1M
J2777	Injection, faricimab‑svoa, 0.1 mg	12,000	$30	$348K
J3490	Unclassified drugs	70	$1,810	$123.1K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	1,010	$90	$87.5K
J2781	Injection, pegcetacoplan, intravitreal, 1 mg	630	$120	$75.6K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	1,260	$60	$71.6K
J7312	Injection, dexamethasone, intravitreal implant, 0.1 mg	240	$150	$37K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	1,270	$30	$34.4K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	350	$90	$29.9K
67036	The provider removes vitreous fluid from the eye to access the posterior segment of the eye and introduce surgical instruments through incisions in the pars plana.	30	$630	$15.8K

Showing 1–10 of 19

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 19 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Indiana Distribution

Howard Lazarus — 4 of 19 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Indiana

Full comparison — all codes billed, vs. state median

19 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	18	60	830	$690	$868.8K
J2777	14	40	6,750	$30	$395.6K
67028	30	80	550	$80	$78.6K
J7312	4	10	280	$160	$47.7K
J2781	1	10	320	$120	$41.9K
67036	7	10	30	$1,040	$37.4K
J3590	41	50	220	$60	$24.5K
66821	226	240	60	$200	$23.1K
67041	7	10	20	$1,000	$22K
92235	22	40	90	$100	$15.8K

Showing 1–10 of 19

Related Providers

Other providers that share a Tax Identification Number (TIN) with Howard Lazarus, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Nathan Steinle	CA	Retina Specialist (Ophthalmology) Physician	$9.5M	$0
Eye Centers Of Louisville,psc	KY	Ophthalmology Physician	$0	$7.5M
Inder Singal	KY	Ophthalmology Physician	$4M	$151.3K
John Kitchens	KY	Retina Specialist (Ophthalmology) Physician	$3.5M	$514.7K
Todd Purkiss	KY	Retina Specialist (Ophthalmology) Physician	$3.9M	$4.8K
Blake Isernhagen	KY	Retina Specialist (Ophthalmology) Physician	$3.2M	$120.3K
Aaron Ricca	KY	Retina Specialist (Ophthalmology) Physician	$2.5M	$307.6K
Steven Bloom	KY	Ophthalmology Physician	$2.3M	$232K
Thomas Stone	KY	Retina Specialist (Ophthalmology) Physician	$2.5M	$520
Miguel Busquets	KY	Retina Specialist (Ophthalmology) Physician	$2.4M	$54.4K

Nearby Providers

Other providers in the same ZIP code as Howard Lazarus, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Baptist Healthcare System, Inc.	IN	General Acute Care Hospital	$0	$34.6M
Nassim And Associates, Psc	IN	Specialist	$0	$13.8M
Ohio Valley Medex Inc	IN	Home Health Agency	$0	$13.5M
Rauch Inc.	IN	Early Intervention Provider Agency	$0	$13.3M
Volunteers Of America Of Kentucky Inc	IN	Voluntary or Charitable Agency	$0	$11.6M
Physicians Medical Center LLC	IN	General Acute Care Hospital	$0	$11.4M
Lifespan Resources	IN	Case Management Agency	$0	$10.7M
Floyd Emergency Medicine Associates PC	IN	Emergency Medicine Physician	$0	$6.6M
Kids Dentistry-new Albany	IN	Dental Clinic/Center	$0	$4.6M
Adaptive Community Support Services Inc	IN	Developmentally Disabled Services Day Training Agency	$0	$4.1M

Howard Lazarus — Billing Profile & Reimbursement Data

Sign up for Howard Lazarus — Billing Profile & Reimbursement Data policy alerts

Howard Lazarus — Billing Profile & Reimbursement Data

Sign up for Howard Lazarus — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References